SC
AXDX

Sculptor Capital’s Accelerate Diagnostics AXDX Stock Holding History

Sculptor Capital’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-900
Closed -$96K – 486
2020
Q3 		$96K Hold
900
– – ﹤0.01% 328
2020
Q2 		$136K Buy
+900
New +$88.7K ﹤0.01% 256
2019
Q3 		– Sell
-5,680
Closed -$1.3M – 298
2019
Q2 		$1.3M Sell
5,680
-320
-5% -$62.6K 0.01% 198
2019
Q1 		$1.26M Buy
+6,000
New +$1.12M 0.01% 156
2018
Q1 		– Sell
-5,310
Closed -$1.39M – 24
2017
Q4 		$1.39M Buy
+5,310
New +$1.24M 0.01% 217

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Sculptor Capital's AXDX Position: Q4 2020 in Review

Sculptor Capital sold out of Accelerate Diagnostics (AXDX) in Q4 2020, closing a stake of 900 shares — an estimated $96K sold.

Sculptor Capital first reported a position in AXDX in Q4 2017 and held it in 5 quarters. The position peaked at $1.39M in Q4 2017. 115 funds tracked by Wall St. Rank hold AXDX as of Q4 2020.

  • Sculptor Capital reported no remaining Accelerate Diagnostics position as of Q4 2020 after selling out during the quarter.
  • Sculptor Capital sold 900 Accelerate Diagnostics shares in Q4 2020, an estimated $96K.
  • Sculptor Capital first reported a position in Accelerate Diagnostics in Q4 2017 and held it in 5 quarters.
  • Sculptor Capital's Accelerate Diagnostics position peaked at $1.39M in Q4 2017.
  • 115 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2020.

Based on Sculptor Capital's 13F filing for Q4 2020, filed 16 Feb 2021.